Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (101-110 of 229) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|January 12, 2013
Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteriaChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2012
Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systemsYun-Hsuan Lee, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Digestive Diseases and Sciences|January 20, 2020
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging DeterminantsShu-Yein Ho, Mei-Hsia Yuan, Chu-Chieh Chen, et al.
Journal of Hepatology|November 10, 2015
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systemsPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Plos One|May 14, 2016
Solitary Large Hepatocellular Carcinoma: Staging and Treatment StrategyPo-Hong Liu, Chien-Wei Su, Chia-Yang Hsu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapyTeh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, et al.
European Journal of Gastroenterology & Hepatology|October 16, 2003
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resectionTeh-Ia Huo, Jaw-Ching Wu, Wing-Yu Lui, et al.
Plos One|June 28, 2013
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral TherapyChien-Wei Su, Yu-Wei Chiou, Yi-Hsuan Tsai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2008
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 yearsChien-Wei Su, Hung-Hsu Hung, Teh-Ia Huo, et al.
Journal of Surgical Oncology|May 29, 2007
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillanceTeh-Ia Huo, Cheng-Yuan Hsia, Chi-Jen Chu, et al.
Pageof 23

Showing results (101-110 of 229) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|January 12, 2013
Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteriaChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 1, 2012
Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systemsYun-Hsuan Lee, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Digestive Diseases and Sciences|January 20, 2020
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging DeterminantsShu-Yein Ho, Mei-Hsia Yuan, Chu-Chieh Chen, et al.
Journal of Hepatology|November 10, 2015
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systemsPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Plos One|May 14, 2016
Solitary Large Hepatocellular Carcinoma: Staging and Treatment StrategyPo-Hong Liu, Chien-Wei Su, Chia-Yang Hsu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapyTeh-Ia Huo, Jaw-Ching Wu, Han-Chieh Lin, et al.
European Journal of Gastroenterology & Hepatology|October 16, 2003
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resectionTeh-Ia Huo, Jaw-Ching Wu, Wing-Yu Lui, et al.
Plos One|June 28, 2013
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral TherapyChien-Wei Su, Yu-Wei Chiou, Yi-Hsuan Tsai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 19, 2008
Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 yearsChien-Wei Su, Hung-Hsu Hung, Teh-Ia Huo, et al.
Journal of Surgical Oncology|May 29, 2007
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillanceTeh-Ia Huo, Cheng-Yuan Hsia, Chi-Jen Chu, et al.
Pageof 23